TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33403790

Group type: EXPERIMENTAL
Intervention: Dermabrasion plus 5-fluorouracil
Number of subjects: 36

Group type: COMPARATOR
Intervention: Suction blister
Number of subjects: 36
Study: 35057647

Group type: EXPERIMENTAL
Intervention: Ebola vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mathematical modeling
Number of subjects: 0
Study: 34207701

Group type: EXPERIMENTAL
Intervention: Multi-component intervention program (exercise with cognitive training) for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-component intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33375123

Group type: EXPERIMENTAL
Intervention: Tailored activity pacing intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 35347164

Group type: EXPERIMENTAL
Intervention: Whole grain rye/rye bran (485 g daily for 6 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Refined wheat (fiber supplemented, 485 g daily for 6 weeks)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Whole grain rye/rye bran
Number of subjects: 17
Study: 33787563

Group type: EXPERIMENTAL
Intervention: Preoperative counseling via phone call
Number of subjects: 120

Group type: COMPARATOR
Intervention: Preoperative counseling via office visit
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative counseling via phone call and office visit
Number of subjects: 120
Study: 32943085

Group type: EXPERIMENTAL
Intervention: Patient-led, fibromyalgia-orientated exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: General exercise program (control)
Number of subjects: 0
Study: 35969401

Group type: EXPERIMENTAL
Intervention: Therapist-supported internet-delivered ERP for tics (111 participants)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Therapist-supported internet-delivered education for tics (110 participants)
Number of subjects: 221
Study: 33175253

Group type: EXPERIMENTAL
Intervention: Immunologically active saliva substitute (IASS)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-immunologically active mouthwash (placebo)
Number of subjects: 94
Study: 34530482

Group type: EXPERIMENTAL
Intervention: Oral apixaban
Number of subjects: 1073

Group type: COMPARATOR
Intervention: Subcutaneous dalteparin
Number of subjects: 1073
Study: 33453190

Group type: EXPERIMENTAL
Intervention: Forced Exercise (FE)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Voluntary Exercise (VE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No Exercise Control
Number of subjects: 100
Study: 35883701

Group type: EXPERIMENTAL
Intervention: Citalopram (acute neuroendocrine challenge)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (acute neuroendocrine challenge)
Number of subjects: 0
Study: 33607357

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (50 mg/day for 8 weeks)
Number of subjects: 51
Study: 32712822

Group type: EXPERIMENTAL
Intervention: Locking Block Modified Krackow (LBMK)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Kessler
Number of subjects: 30

Group type: COMPARATOR
Intervention: Percutaneous Achilles Repair System (PARS)
Number of subjects: 30
Study: 36378307

Group type: EXPERIMENTAL
Intervention: Single wound infiltration with bupivacaine and adrenaline
Number of subjects: 288

Group type: COMPARATOR
Intervention: No single wound infiltration
Number of subjects: 288
Study: 32990605

Group type: EXPERIMENTAL
Intervention: Enteral ecoimmunonutrition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 60
Study: 33587510

Group type: EXPERIMENTAL
Intervention: VRC01 10 mg/kg
Number of subjects: 1924

Group type: EXPERIMENTAL
Intervention: VRC01 30 mg/kg
Number of subjects: 1924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1924
Study: 32061185

Group type: EXPERIMENTAL
Intervention: Adapted tango intervention (20 sessions of 90-min classes over 12 weeks)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Adapted tango intervention
Number of subjects: 62
Study: 35079243

Group type: EXPERIMENTAL
Intervention: Teledentistry diagnoses
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Teledentistry
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (traditional dental visits)
Number of subjects: 70
Study: 32978188

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (SA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 120
Study: 33395586

Group type: EXPERIMENTAL
Intervention: Rosa damascene essence 40% in distilled water inhalation for three consecutive nights from 22:00 to 06:00
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water inhalation as placebo for three consecutive nights from 22:00 to 06:00
Number of subjects: 60
Study: 35606864

Group type: EXPERIMENTAL
Intervention: Rosa canina L. syrup + methylphenidate (MP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (PHF) syrup + methylphenidate (MP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo + methylphenidate (MP)
Number of subjects: 90
Study: 34921679

Group type: EXPERIMENTAL
Intervention: Test cream containing ceramides, triglycerides, and cholesterol in a multivesicular emulsion
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Test cream
Number of subjects: 34

Group type: COMPARATOR
Intervention: Reference emollient cream
Number of subjects: 34
Study: 32731878

Group type: EXPERIMENTAL
Intervention: Artificial neural networks (ANN) model for early prediction of outcome
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: Simplified ANN model using three variables (age, time to ROSC, first monitored rhythm)
Number of subjects: 932

Group type: COMPARATOR
Intervention: Targeted temperature management (TTM) at 33°C or 36°C
Number of subjects: 932
Study: 35022320

Group type: EXPERIMENTAL
Intervention: HCQ 600 mg po bid with D+T (dabrafenib 150 mg bid and trametinib 2 mg qd)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: HCQ+D+T in patients with elevated LDH (n=16)
Number of subjects: 34
Study: 33045853

Group type: EXPERIMENTAL
Intervention: Epigallocatechin gallate (EGCG)
Number of subjects: 0
Study: 33064385

Group type: EXPERIMENTAL
Intervention: D group (drain placement)
Number of subjects: 400

Group type: COMPARATOR
Intervention: ND group (no drain placement)
Number of subjects: 400
Study: 33357482

Group type: EXPERIMENTAL
Intervention: RVd
Number of subjects: 100

Group type: COMPARATOR
Intervention: RVd-elotuzumab
Number of subjects: 100
Study: 32860991

Group type: EXPERIMENTAL
Intervention: Sprifermin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sprifermin (highest dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 616484845

Group type: EXPERIMENTAL
Intervention: Giant exercising board game intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 36056419

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg body weight) in addition to the standard of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 0
Study: 33871742

Group type: EXPERIMENTAL
Intervention: Intensive implementation support (toolkits, clinical training, implementation facilitation, data-based feedback)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control condition (manual only)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Illness management and recovery
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Physical health care
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Antipsychotic medication management
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Number of subjects: 39
Study: 35795633

Group type: EXPERIMENTAL
Intervention: Treat-and-Extend (T&E) regimen
Number of subjects: 141

Group type: COMPARATOR
Intervention: Pro Re Nata (PRN) regimen
Number of subjects: 141
Study: 33401241

Group type: COMPARATOR
Intervention: Repeated-sprint running (6 × 40 m)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Easy exercise (4 × 12 fast half squats, 6 speed ladder drills, and 20-m sprints)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Control (no exercise)
Number of subjects: 12
Study: 33468068

Group type: EXPERIMENTAL
Intervention: Cardiac Peri‐Operative Transfusion Trigger Score (cPOTTS) group
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conventional evaluation of the need for transfusion (conventional group)
Number of subjects: 500
Study: 35248785

Group type: COMPARATOR
Intervention: Bilateral dual tDCS (bi-tDCS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unilateral anodal tDCS (ua-tDCS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 24
Study: 33337926

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (laser)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32845328

Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention in home setting
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention in clinic setting
Number of subjects: 183
Study: 35775704

Group type: EXPERIMENTAL
Intervention: Conventional photodynamic therapy (c‐PDT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (dl‐PDT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 50
Study: 32134326

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 5109

Group type: EXPERIMENTAL
Intervention: Moderate fitness (tertile 2)
Number of subjects: 5109

Group type: EXPERIMENTAL
Intervention: High fitness (tertile 3)
Number of subjects: 5109

Group type: EXPERIMENTAL
Intervention: Improvements in cardiorespiratory fitness (CRF)
Number of subjects: 5109

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 5109

Group type: COMPARATOR
Intervention: Diabetes support and education (control)
Number of subjects: 5109
Study: 37702629

Group type: EXPERIMENTAL
Intervention: Lazertinib
Number of subjects: 258

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 258
Study: 34479508

Group type: EXPERIMENTAL
Intervention: Reconsolidation Therapy (RT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 46
Study: 32925713

Group type: EXPERIMENTAL
Intervention: Yangyin Shuxin Decoction combined with standard treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 64
Study: 35452347

Group type: EXPERIMENTAL
Intervention: Semi-rigid backpack type thoracolumbar orthosis (TLO)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no external support or exercise)
Number of subjects: 48
Study: 33413555

Group type: EXPERIMENTAL
Intervention: C‐Mill training (10 sessions, 1 hour each, twice per week for 5 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 32445690

Group type: EXPERIMENTAL
Intervention: Minocycline plus Celecoxib
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Minocycline plus Placebo
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Celecoxib plus Placebo
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo plus Placebo
Number of subjects: 266
Study: 34396891

Group type: EXPERIMENTAL
Intervention: Combined plyometric and balance exercises (PLYO-BAL group; n=19)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Plyometric exercises (PLYO group; n=19)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Balance exercises (BAL group; n=19)
Number of subjects: 57
Study: 34610049

Group type: EXPERIMENTAL
Intervention: Screened for AF using a continuous-recording ECG patch worn for two weeks and 2 occasions, 3 months apart.
Number of subjects: 5089

Group type: COMPARATOR
Intervention: Observational controls (no screening).
Number of subjects: 5089
Study: 32093339

Group type: EXPERIMENTAL
Intervention: Strength exercise with 25-30% caloric restriction diet
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Endurance exercise with 25-30% caloric restriction diet
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combined strength + endurance exercise with 25-30% caloric restriction diet
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Guideline-based physical activity with 25-30% caloric restriction diet
Number of subjects: 162

Group type: COMPARATOR
Intervention: All groups (combined)
Number of subjects: 162
Study: 35458098

Group type: EXPERIMENTAL
Intervention: Experimental group (school garden attendance)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual content on the human body and health)
Number of subjects: 0
Study: 33781780

Group type: EXPERIMENTAL
Intervention: Continuous chest wall vibration with concurrent aerobic training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham intervention (placebo continuous chest wall vibration)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 40
Study: 34989089

Group type: EXPERIMENTAL
Intervention: 3D models (n=65)
Number of subjects: 13

Group type: COMPARATOR
Intervention: AMIGO method (n=65)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 3D models
Number of subjects: 13
Study: 32928904

Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 134
Study: 33062081

Group type: EXPERIMENTAL
Intervention: ET + RT + NMES
Number of subjects: 42

Group type: COMPARATOR
Intervention: ET + RT
Number of subjects: 42
Study: 35885537

Group type: EXPERIMENTAL
Intervention: Intubrite laryngoscope
Number of subjects: 50

Group type: COMPARATOR
Intervention: Macintosh laryngoscope (MCL)
Number of subjects: 50
Study: 33188050

Group type: EXPERIMENTAL
Intervention: Nivolumab + ipilimumab
Number of subjects: 847

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 847
Study: 35717200

Group type: EXPERIMENTAL
Intervention: ECM scaffold (small intestinal submucosa [SIS]) + intrauterine balloon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intrauterine balloon only
Number of subjects: 0
Study: 35599465

Group type: EXPERIMENTAL
Intervention: Ankle proprioceptive training with thermal stimulation (APT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conservative treatment (Control)
Number of subjects: 30
Study: 34444363

Group type: EXPERIMENTAL
Intervention: Highly fantastical animations
Number of subjects: 218

Group type: COMPARATOR
Intervention: Low-fantastical animations
Number of subjects: 218

Group type: COMPARATOR
Intervention: Pacing
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Age-related improvements
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Fantasy in younger children
Number of subjects: 218
Study: 32221067

Group type: EXPERIMENTAL
Intervention: PBM (photobiomodulation)
Number of subjects: 34

Group type: COMPARATOR
Intervention: PBM simulation (placebo)
Number of subjects: 34
Study: 35867398

Group type: EXPERIMENTAL
Intervention: VR nature experiences (Ripple or Happy Place)
Number of subjects: 38
Study: 33098278

Group type: EXPERIMENTAL
Intervention: LM+SHARE
Number of subjects: 77

Group type: COMPARATOR
Intervention: LM
Number of subjects: 77
Study: 32715381

Group type: COMPARATOR
Intervention: ASP3652 (300 mg bid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ASP3652 (600–1800 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34932511

Group type: EXPERIMENTAL
Intervention: Omega Scanner 3D
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rodin4D
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Biosculptor
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 30
Study: 33676597

Group type: EXPERIMENTAL
Intervention: Azithromycin plus usual care
Number of subjects: 2265

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 2265
Study: 35710384

Group type: EXPERIMENTAL
Intervention: Inadequate GWG
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Inadequate GWG (percentage of GWG adequacy)
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Excessive GWG among women with normal BMI
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Adequate GWG
Number of subjects: 1230
Study: 34843312

Group type: EXPERIMENTAL
Intervention: Internet-based treatment (IG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control group (WCG)
Number of subjects: 200
Study: 36187680

Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for overall survival (OS)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for cancer-specific survival (CSS)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Calibration curves of the nomograms
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA)
Number of subjects: 232
Study: 36160327

Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nature videos (control)
Number of subjects: 27
Study: 32311977

Group type: EXPERIMENTAL
Intervention: Qizhi Weitong granules (QZWTG)
Number of subjects: 384
Study: 34861953

Group type: EXPERIMENTAL
Intervention: 7-week education program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 32873533

Group type: EXPERIMENTAL
Intervention: Meeting sexual partners online
Number of subjects: 14537
Study: 35526703

Group type: EXPERIMENTAL
Intervention: Text-only sugar warning label
Number of subjects: 2219

Group type: EXPERIMENTAL
Intervention: Pictorial sugar warning label
Number of subjects: 2219

Group type: COMPARATOR
Intervention: Barcode control
Number of subjects: 2219

Group type: EXPERIMENTAL
Intervention: Text and pictorial sugar warning labels
Number of subjects: 2219
Study: 34766912

Group type: EXPERIMENTAL
Intervention: Fitbit Flex and biweekly phone calls with a study physiotherapist (PT) during an 8-week physical activity counseling intervention
Number of subjects: 21
Study: 33130860

Group type: EXPERIMENTAL
Intervention: Personalized handwritten sympathy cards
Number of subjects: 393
Study: 616314157

Group type: EXPERIMENTAL
Intervention: Extended duration weight-loss programme referrals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard duration weight-loss programme referrals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief intervention group
Number of subjects: 0
Study: 35501120

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI) in one eye
Number of subjects: 889

Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 889
Study: 33580603

Group type: EXPERIMENTAL
Intervention: KRP-116D (50% dimethyl sulfoxide solution)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: KRP-116D
Number of subjects: 96
Study: 36217645

Group type: EXPERIMENTAL
Intervention: Piroxicam (20 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 120
Study: 35279317

Group type: EXPERIMENTAL
Intervention: Heel off-loading boot
Number of subjects: 394
Study: 35866200

Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational video in Moroccan-Arabic, Berber, and Turkish
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current information brochure
Number of subjects: 0
Study: 34303602

Group type: EXPERIMENTAL
Intervention: In-class intervention with parental feeding content
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Online intervention with parental feeding content
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no parental feeding content)
Number of subjects: 11
Study: 32183886

Group type: EXPERIMENTAL
Intervention: Aerosolized dornase alfa
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 35657784

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (300,000 IU)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33667670

Group type: EXPERIMENTAL
Intervention: Mirvetuximab soravtansine (MIRV)
Number of subjects: 366
Study: 35850911

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 0
Study: 33513485

Group type: EXPERIMENTAL
Intervention: CYP2D6 genotype and functional status treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard psychotropic therapy
Number of subjects: 0
Study: 32302640

Group type: EXPERIMENTAL
Intervention: Glass fiber posts
Number of subjects: 119

Group type: COMPARATOR
Intervention: Cast metal posts
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both post types
Number of subjects: 119
Study: 36151980

Group type: EXPERIMENTAL
Intervention: Pain management programme
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 64
Study: 34113353

Group type: EXPERIMENTAL
Intervention: estradiol (E2) patch
Number of subjects: 36

Group type: COMPARATOR
Intervention: transdermal placebo
Number of subjects: 36
Study: 35614185

Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) supplementation (4.5 g daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Maltodextrin (control)
Number of subjects: 15
Study: 34089219

Group type: EXPERIMENTAL
Intervention: VAIA (vincristine, dactinomycin, doxorubicin, and ifosfamide) or VACA II (cyclophosphamide) in CWS-91
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: VAIA or CEVAIE (+carboplatin and etoposide) in CWS-96
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: VAIA III plus optional maintenance therapy (MT) in CWS-2002P
Number of subjects: 243
Study: 34879312

Group type: EXPERIMENTAL
Intervention: Activity tracker (Fitbit Flex 2) used for 7 days at baseline and 7 days before the 2-month follow-up assessment.
Number of subjects: 65
Study: 33929522

Group type: EXPERIMENTAL
Intervention: Intervention group (n=3732 in phase 1, n=6645 in phase 2) received a nurse-led Joint Asia Diabetes Evaluation (JADE) technology-guided structured evaluation, automated personalized reports, and 2 or more contacts by nurses.
Number of subjects: 20834

Group type: COMPARATOR
Intervention: Control group (n=3805 in phase 1, n=6652 in phase 2) received the JADE technology-guided structured evaluation and automated personalized reports (phase 1) or only the JADE technology-guided structured evaluation (phase 2).
Number of subjects: 20834
Study: 34522175

Group type: EXPERIMENTAL
Intervention: Short-axis hydrodissection (5 mL normal saline per session)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Long-axis hydrodissection (5 mL normal saline per session)
Number of subjects: 44
Study: 32593154

Group type: EXPERIMENTAL
Intervention: alpha-tACS
Number of subjects: 30

Group type: COMPARATOR
Intervention: sham-tACS
Number of subjects: 30